相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cohort study of trials submitted to ethics committee identified discrepant reporting of outcomes in publications
Shelagh Redmond et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial
Volker Moebus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2012)
Erythropoietin receptor contributes to melanoma cell survival in vivo
S. M. Kumar et al.
ONCOGENE (2012)
Open Clinical Trial Data for All? A View from Regulators
Hans-Georg Eichler et al.
PLOS MEDICINE (2012)
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer-outcome on prognosis
M. Untch et al.
ANNALS OF ONCOLOGY (2011)
Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation
Y. Fujisaka et al.
BRITISH JOURNAL OF CANCER (2011)
How to Obtain NNT from Cohen's d: Comparison of Two Methods
Toshi A. Furukawa et al.
PLOS ONE (2011)
Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
D. Schrijvers et al.
ANNALS OF ONCOLOGY (2010)
Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents
Charles L. Bennett et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
J. Glaspy et al.
BRITISH JOURNAL OF CANCER (2010)
American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
J. Douglas Rizzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial
Andreas Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial
Paolo Pronzato et al.
ONCOLOGIST (2010)
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α: a prospective randomized controlled trial of the ELYPSE study group
I. Ray-Coquard et al.
ANNALS OF ONCOLOGY (2009)
Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2009)
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
Marcello Tonelli et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Role of recombinant human erythropoietin in patients of advanced cervical cancer treated by chemoradiotherapy
Seema Gupta et al.
CANCER BIOLOGY & THERAPY (2009)
Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia
Enrique Hernandez et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study
Masahiro Tsuboi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Randomized, Double-Blind, Placebo-Controlled Trial of Epoetin Alfa in Men With Castration-Resistant Prostate Cancer and Anemia
Eric Winquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia
Heinz Ludwig et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer
Peter J. Hoskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
S. Suzuki et al.
ANNALS OF ONCOLOGY (2008)
Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer:: an updated meta-analysis of 12 randomised controlled studies including 2301 patients
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2008)
Epoetin Delta: Efficacy in the Treatment of Anaemia in Cancer Patients Receiving Chemotherapy
M. Krzakowski
CLINICAL ONCOLOGY (2008)
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
Gillian Thomas et al.
GYNECOLOGIC ONCOLOGY (2008)
Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer
H. -G. Strauss et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study
Matti Aapro et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
Robert E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Safety and efficacy of darbepoetin alfa in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide
Robert Pirker et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue
Ollie Minton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Treating anemia of cancer with every-4-week darbepoetin alfa: Final efficacy and safety results from a phase II, randomized, double-blind, placebo-controlled study
David Gordon et al.
ONCOLOGIST (2008)
September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents
Matti S. Aapro et al.
ONCOLOGIST (2008)
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: A randomized trial of the radiation therapy oncology group (RTOG 99-03)
Mitchell Machtay et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Meta-analysis: Chondroitin for osteoarthritis of the knee or hip
Stephan Reichenbach et al.
ANNALS OF INTERNAL MEDICINE (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase II trial
Veena Charu et al.
ONCOLOGIST (2007)
The clinical significance of quality of life assessments in oncology: a summary for clinicians
Jeff A. Sloan et al.
SUPPORTIVE CARE IN CANCER (2006)
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
Julia Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
PM Wilkinson et al.
BRITISH JOURNAL OF CANCER (2006)
Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
JH Savonije et al.
EUROPEAN JOURNAL OF CANCER (2005)
Impact of maintaining Hb with epoetin alfa on time to progression (TTP), overall survival (OS), quality of life (QOL) and transfusion reduction in limited disease SCLC patients
G Goss et al.
LUNG CANCER (2005)
Epoetin alfa and survival in patients with non-resectable NSCLC - Interim results
J Debus
LUNG CANCER (2005)
Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy
J Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
D Kotasek et al.
EUROPEAN JOURNAL OF CANCER (2003)
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies:: a randomized, double-blind, placebo-controlled study
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: Results of a randomized, controlled trial
G Iconomou et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2003)
Impact of epoetin β on quality of life in patients with malignant disease
M Boogaerts et al.
BRITISH JOURNAL OF CANCER (2003)
Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population
D Cella et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Multivariate regression analyses of data from a randomized, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy
L Fallowfield et al.
BRITISH JOURNAL OF CANCER (2002)
Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales
D Cella et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life
D Cella et al.
MAYO CLINIC PROCEEDINGS (2002)
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head
JA Berlin et al.
STATISTICS IN MEDICINE (2002)
Epidemiology and etiology of Hodgkin's lymphoma
RK Thomas et al.
ANNALS OF ONCOLOGY (2002)
Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
F Dammacco et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
